Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.

por Watanabe, J., Sato, Y., Kuramoto, H., Kameya, T.
Publicado 1995

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters

por Watanabe, J, Sato, H, Kanai, T, Kamata, Y, Jobo, T, Hata, H, Fujisawa, T, Ohno, E, Kameya, T, Kuramoto, H
Publicado 2002

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

por Katsumata, N, Noda, K, Nozawa, S, Kitagawa, R, Nishimura, R, Yamaguchi, S, Aoki, D, Susumu, N, Kuramoto, H, Jobo, T, Ueki, K, Ueki, M, Kohno, I, Fujiwara, K, Sohda, Y, Eguchi, F
Publicado 2005

The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas

por Shoji, K, Oda, K, Nakagawa, S, Hosokawa, S, Nagae, G, Uehara, Y, Sone, K, Miyamoto, Y, Hiraike, H, Hiraike-Wada, O, Nei, T, Kawana, K, Kuramoto, H, Aburatani, H, Yano, T, Taketani, Y
Publicado 2009

Reply: Somatic mutations are present in all members of the AKT family in endometrial carcinoma

por Shoji, K, Oda, K, Nakagawa, S, Hosokawa, S, Nagae, G, Uehara, Y, Sone, K, Miyamoto, Y, Hiraike, H, Hiraike-Wada, O, Nei, T, Kawana, K, Kuramoto, H, Aburatani, H, Yano, T, Taketani, Y
Publicado 2009